{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:39:51Z","timestamp":1787240391631,"version":"build-2736575974"},"reference-count":207,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018231","name":"Aligning Science Across Parkinson's","doi-asserted-by":"publisher","award":["ASAP-020527"],"award-info":[{"award-number":["ASAP-020527"]}],"id":[{"id":"10.13039\/100018231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","award":["PF-JFA-830658"],"award-info":[{"award-number":["PF-JFA-830658"]}],"id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES032440"],"award-info":[{"award-number":["R01 ES032440"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1NS128800"],"award-info":[{"award-number":["RF1NS128800"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01NS113851"],"award-info":[{"award-number":["U01NS113851"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS064934"],"award-info":[{"award-number":["R01 NS064934"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX002230"],"award-info":[{"award-number":["I01 BX002230"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastrointestinal (GI) involvement in Lewy body diseases (LBDs) has been observed since the initial descriptions of patients by James Parkinson. Recent experimental and human observational studies raise the possibility that pathogenic alpha-synuclein (\u237a-syn) might develop in the GI tract and subsequently spread to susceptible brain regions. The cellular and mechanistic origins of \u237a-syn propagation in disease are under intense investigation. Experimental LBD models have implicated important contributions from the intrinsic gut microbiome, the intestinal immune system, and environmental toxicants, acting as triggers and modifiers to GI pathologies. Here, we review the primary clinical observations that link GI dysfunctions to LBDs. We first provide an overview of GI anatomy and the cellular repertoire relevant for disease, with a focus on luminal-sensing cells of the intestinal epithelium including enteroendocrine cells that express \u237a-syn and make direct contact with nerves. We describe interactions within the GI tract with resident microbes and exogenous toxicants, and how these may directly contribute to \u237a-syn pathology along with related metabolic and immunological responses. Finally, critical knowledge gaps in the field are highlighted, focusing on pivotal questions that remain some 200 years after the first descriptions of GI tract dysfunction in LBDs. We predict that a better understanding of how pathophysiologies in the gut influence disease risk and progression will accelerate discoveries that will lead to a deeper overall mechanistic understanding of disease and potential therapeutic strategies targeting the gut-brain axis to delay, arrest, or prevent disease progression.<\/jats:p>","DOI":"10.1186\/s13024-025-00804-5","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:32:27Z","timestamp":1738225947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lewy body diseases and the gut"],"prefix":"10.1186","volume":"20","author":[{"given":"Timothy R.","family":"Sampson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mal\u00fa G\u00e1mez","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3034-4061","authenticated-orcid":false,"given":"Andrew B.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodger A.","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"issue":"2","key":"804_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1176\/jnp.14.2.223","volume":"14","author":"J Parkinson","year":"2002","unstructured":"Parkinson J. An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci. 2002;14(2):223\u201336 discussion 2.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"1","key":"804_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mds.870010104","volume":"1","author":"CG Goetz","year":"1986","unstructured":"Goetz CG. Charcot on Parkinson\u2019s disease. Mov Disord. 1986;1(1):27\u201332.","journal-title":"Mov Disord"},{"issue":"2","key":"804_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","volume":"2","author":"RF Pfeiffer","year":"2003","unstructured":"Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2003;2(2):107\u201316.","journal-title":"Lancet Neurol"},{"issue":"6","key":"804_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","volume":"14","author":"A Fasano","year":"2015","unstructured":"Fasano A, Visanji NP, Liu LW, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson\u2019s disease. Lancet Neurol. 2015;14(6):625\u201339.","journal-title":"Lancet Neurol"},{"issue":"2","key":"804_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/jnnp.74.2.268","volume":"74","author":"R Sakakibara","year":"2003","unstructured":"Sakakibara R, Odaka T, Uchiyama T, Asahina M, Yamaguchi K, Yamaguchi T, et al. Colonic transit time and rectoanal videomanometry in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2003;74(2):268\u201372.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"804_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JPD-161050","volume":"7","author":"K Knudsen","year":"2017","unstructured":"Knudsen K, Fedorova TD, Bekker AC, Iversen P, \u00d8stergaard K, Krogh K, et al. Objective colonic dysfunction is far more prevalent than subjective constipation in Parkinson\u2019s disease: a colon transit and volume study. J Parkinsons Dis. 2017;7(2):359\u201367.","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"804_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","volume":"8","author":"T Warnecke","year":"2022","unstructured":"Warnecke T, Sch\u00e4fer KH, Claus I, Del Tredici K, Jost WH. Gastrointestinal involvement in Parkinson\u2019s disease: pathophysiology, diagnosis, and management. NPJ Parkinsons Dis. 2022;8(1):31.","journal-title":"NPJ Parkinsons Dis"},{"issue":"3","key":"804_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella M, Severgnini M, Cilia R, Cassani E, Bolliri C, Caronni S, et al. Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov Disord. 2019;34(3):396\u2013405.","journal-title":"Mov Disord"},{"issue":"11","key":"804_CR9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22(11):657\u201373.","journal-title":"Nat Rev Immunol"},{"key":"804_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106774","volume":"207","author":"S Kola","year":"2021","unstructured":"Kola S, Prichard DO, Bharucha AE, Hassan A. A prospective pilot study of the effects of deep brain stimulation on olfaction and constipation in Parkinson\u2019s disease. Clin Neurol Neurosurg. 2021;207:106774.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"804_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41575-018-0078-6","volume":"16","author":"SC Payne","year":"2019","unstructured":"Payne SC, Furness JB, Stebbing MJ. Bioelectric neuromodulation for gastrointestinal disorders: effectiveness and mechanisms. Nat Rev Gastroenterol Hepatol. 2019;16(2):89\u2013105.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"804_CR12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88\u2013100.","journal-title":"Neurology"},{"issue":"1","key":"804_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.23922\/jarc.2018-022","volume":"3","author":"R Sakakibara","year":"2019","unstructured":"Sakakibara R, Doi H, Fukudo S. Lewy body constipation. J Anus Rectum Colon. 2019;3(1):10\u20137.","journal-title":"J Anus Rectum Colon"},{"key":"804_CR14","doi-asserted-by":"publisher","first-page":"105244","DOI":"10.1016\/j.parkreldis.2022.105244","volume":"107","author":"E Camerucci","year":"2023","unstructured":"Camerucci E, Mullan AF, Bower JH, Bharucha AE, Turcano P, Stang CD, et al. Lifelong constipation in Parkinson\u2019s disease and other clinically defined alpha-synucleinopathies: a population-based study in Southeast Minnesota. Parkinsonism Relat Disord. 2023;107:105244.","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"804_CR15","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/oxfordjournals.aje.a117721","volume":"142","author":"R Mayeux","year":"1995","unstructured":"Mayeux R, Marder K, Cote LJ, Denaro J, Hemenegildo N, Mejia H, et al. The frequency of idiopathic Parkinson\u2019s disease by age, ethnic group, and sex in northern Manhattan, 1988\u20131993. Am J Epidemiol. 1995;142(8):820\u20137.","journal-title":"Am J Epidemiol"},{"issue":"11","key":"804_CR16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/aje\/kwg068","volume":"157","author":"SK Van Den Eeden","year":"2003","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003;157(11):1015\u201322.","journal-title":"Am J Epidemiol"},{"issue":"14","key":"804_CR17","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1212\/WNL.0000000000004382","volume":"89","author":"H Chen","year":"2017","unstructured":"Chen H, Shrestha S, Huang X, Jain S, Guo X, Tranah GJ, et al. Olfaction and incident Parkinson disease in US white and black older adults. Neurology. 2017;89(14):1441\u20137.","journal-title":"Neurology"},{"issue":"4","key":"804_CR18","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/mds.28494","volume":"36","author":"GP2","year":"2021","unstructured":"GP2. The global Parkinson\u2019s genetics program. Mov Disord. 2021;36(4):842\u201351.","journal-title":"Mov Disord"},{"issue":"15","key":"804_CR19","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370.","journal-title":"Mov Disord"},{"issue":"1","key":"804_CR20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mds.30051","volume":"40","author":"K Step","year":"2025","unstructured":"Step K, Eltaraifee E, Elsayed I, Rasaholiarison N, Okubadejo N, Walker R, et al. Advancing Parkinson\u2019s disease research in Africa: a strategic training framework of the global Parkinson\u2019s genetics program. Mov Disord. 2025;40(1):51\u20136.","journal-title":"Mov Disord"},{"issue":"11","key":"804_CR21","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3748\/wjg.v27.i11.1055","volume":"27","author":"M Zhang","year":"2021","unstructured":"Zhang M, Yang S, Li XC, Zhu HM, Peng D, Li BY, et al. Study on the characteristics of intestinal motility of constipation in patients with Parkinson\u2019s disease. World J Gastroenterol. 2021;27(11):1055\u201363.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"804_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","volume":"18","author":"ZS Heetun","year":"2012","unstructured":"Heetun ZS, Quigley EM. Gastroparesis and Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2012;18(5):433\u201340.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"804_CR23","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1365-2982.2006.00780.x","volume":"18","author":"O Goetze","year":"2006","unstructured":"Goetze O, Nikodem AB, Wiezcorek J, Banasch M, Przuntek H, Mueller T, et al. Predictors of gastric emptying in Parkinson\u2019s disease. Neurogastroenterol Motil. 2006;18(5):369\u201375.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"804_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/mds.25708","volume":"29","author":"S Marrinan","year":"2014","unstructured":"Marrinan S, Emmanuel AV, Burn DJ. Delayed gastric emptying in Parkinson\u2019s disease. Mov Disord. 2014;29(1):23\u201332.","journal-title":"Mov Disord"},{"issue":"1","key":"804_CR25","first-page":"15","volume":"89","author":"LL Edwards","year":"1994","unstructured":"Edwards LL, Quigley EM, Harned RK, Hofman R, Pfeiffer RF. Characterization of swallowing and defecation in Parkinson\u2019s disease. Am J Gastroenterol. 1994;89(1):15\u201325.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"804_CR26","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1007\/s00415-013-7085-x","volume":"260","author":"M Picillo","year":"2013","unstructured":"Picillo M, Amboni M, Erro R, Longo K, Vitale C, Moccia M, et al. Gender differences in non-motor symptoms in early, drug na\u00efve Parkinson\u2019s disease. J Neurol. 2013;260(11):2849\u201355.","journal-title":"J Neurol"},{"issue":"11","key":"804_CR27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.parkreldis.2014.08.013","volume":"20","author":"P Srivanitchapoom","year":"2014","unstructured":"Srivanitchapoom P, Pandey S, Hallett M. Drooling in Parkinson\u2019s disease: a review. Parkinsonism Relat Disord. 2014;20(11):1109\u201318.","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"804_CR28","first-page":"1741","volume":"90","author":"BT Johnston","year":"1995","unstructured":"Johnston BT, Li Q, Castell JA, Castell DO. Swallowing and esophageal function in Parkinson\u2019s disease. Am J Gastroenterol. 1995;90(10):1741\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"804_CR29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/mds.25522","volume":"28","author":"A Fasano","year":"2013","unstructured":"Fasano A, Bove F, Gabrielli M, Petracca M, Zocco MA, Ragazzoni E, et al. The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease. Mov Disord. 2013;28(9):1241\u20139.","journal-title":"Mov Disord"},{"issue":"3","key":"804_CR30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/jcm10030493","volume":"10","author":"C Skj\u00e6rb\u00e6k","year":"2021","unstructured":"Skj\u00e6rb\u00e6k C, Knudsen K, Horsager J, Borghammer P. Gastrointestinal dysfunction in Parkinson\u2019s disease. J Clin Med. 2021;10(3):625.","journal-title":"J Clin Med"},{"key":"804_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-140","volume":"13","author":"E Londos","year":"2013","unstructured":"Londos E, Hanxsson O, Alm Hirsch I, Janneskog A, B\u00fclow M, Palmqvist S. Dysphagia in Lewy body dementia - a clinical observational study of swallowing function by videofluoroscopic examination. BMC Neurol. 2013;13:140.","journal-title":"BMC Neurol"},{"key":"804_CR32","first-page":"3","volume-title":"The enteric nervous system","author":"JB Furness","year":"2006","unstructured":"Furness JB. The enteric nervous system. Oxford, U.K.: Blackwell; 2006. p. 3\u201313."},{"key":"804_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-1-4939-0897-4_3","volume":"817","author":"JB Furness","year":"2014","unstructured":"Furness JB, Callaghan BP, Rivera LR, Cho HJ. The enteric nervous system and gastrointestinal innervation: integrated local and central control. Adv Exp Med Biol. 2014;817:39\u201371.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"804_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1152\/physrev.00018.2022","volume":"103","author":"KA Sharkey","year":"2023","unstructured":"Sharkey KA, Mawe GM. The enteric nervous system. Physiol Rev. 2023;103(2):1487\u2013564.","journal-title":"Physiol Rev"},{"key":"804_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/B978-0-12-382026-6.00019-1","volume-title":"Physiology of the gastrointestinal tract","author":"DP Poole","year":"2012","unstructured":"Poole DP, Furness JB. Enteric nervous system structure and neurochemistry related to function and neuropathology. In: Johnson LR, Ghishan FK, Kaunitz JD, Merchant JL, Said HM, Wood JD, editors. Physiology of the gastrointestinal tract. 1 5. London, U.K: Elsevier; 2012. p. 557\u201381.","edition":"1 5"},{"issue":"4","key":"804_CR36","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/0016-5085(84)90079-9","volume":"87","author":"SJ Qualman","year":"1984","unstructured":"Qualman SJ, Haupt HM, Yang P, Hamilton SR. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson\u2019s disease. Gastroenterology. 1984;87(4):848\u201356.","journal-title":"Gastroenterology"},{"issue":"6","key":"804_CR37","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 2010;119(6):689\u2013702.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"804_CR38","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1136\/gut.2008.162503","volume":"57","author":"T Lebouvier","year":"2008","unstructured":"Lebouvier T, Chaumette T, Damier P, Coron E, Touchefeu Y, Vrignaud S, et al. Pathological lesions in colonic biopsies during Parkinson\u2019s disease. Gut. 2008;57(12):1741\u20133.","journal-title":"Gut"},{"issue":"6","key":"804_CR39","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/mds.24993","volume":"27","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Neunlist M, Derkinderen P. Lewy pathology in gastric and duodenal biopsies in Parkinson\u2019s disease. Mov Disord. 2012;27(6):708.","journal-title":"Mov Disord"},{"issue":"6","key":"804_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/mds.23838","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, Daian D, Jaglin JA, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson\u2019s disease. Mov Disord. 2012;27(6):709\u201315.","journal-title":"Mov Disord"},{"issue":"3","key":"804_CR41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF00687767","volume":"76","author":"K Wakabayashi","year":"1988","unstructured":"Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson\u2019s disease: the presence of Lewy bodies in Auerbach\u2019s and Meissner\u2019s plexuses. Acta Neuropathol. 1988;76(3):217\u201321.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"804_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett. 2006;396(1):67\u201372.","journal-title":"Neurosci Lett"},{"issue":"6","key":"804_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/BF00294234","volume":"79","author":"K Wakabayashi","year":"1990","unstructured":"Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson\u2019s disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol. 1990;79(6):581\u20133.","journal-title":"Acta Neuropathol"},{"key":"804_CR44","doi-asserted-by":"publisher","first-page":"476041","DOI":"10.1155\/2015\/476041","volume":"2015","author":"MG Cersosimo","year":"2015","unstructured":"Cersosimo MG. Gastrointestinal biopsies for the diagnosis of Alpha-Synuclein Pathology in Parkinson\u2019s disease. Gastroenterol Res Pract. 2015;2015:476041.","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"804_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","volume":"120","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol. 2010;120(1):1\u201312.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"804_CR46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, Stephens M, Kirk L, Edwards P, Potter R, Zajicek J, et al. Accumulation of alpha-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127(2):235\u201341.","journal-title":"Acta Neuropathol"},{"issue":"10","key":"804_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","volume":"82","author":"CH Adler","year":"2014","unstructured":"Adler CH, Dugger BN, Hinni ML, Lott DG, Driver-Dunckley E, Hidalgo J, et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology. 2014;82(10):858\u201364.","journal-title":"Neurology"},{"issue":"4","key":"804_CR48","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/mds.25988","volume":"30","author":"A Sanchez-Ferro","year":"2015","unstructured":"Sanchez-Ferro A, Rabano A, Catalan MJ, Rodriguez-Valcarcel FC, Fernandez Diez S, Herreros-Rodriguez J, et al. In vivo gastric detection of alpha-synuclein inclusions in Parkinson\u2019s disease. Mov Disord. 2015;30(4):517\u201324.","journal-title":"Mov Disord"},{"issue":"9","key":"804_CR49","doi-asserted-by":"publisher","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N\u2019Guyen JM, et al. Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS ONE. 2010;5(9):e12728.","journal-title":"PLoS ONE"},{"issue":"4","key":"804_CR50","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1111\/j.1365-2982.2012.01887.x","volume":"24","author":"H Pouclet","year":"2012","unstructured":"Pouclet H, Lebouvier T, Coron E, Des Varannes SB, Neunlist M, Derkinderen P. A comparison between colonic submucosa and mucosa to detect Lewy pathology in Parkinson\u2019s disease. Neurogastroenterol Motil. 2012;24(4):e202\u20135.","journal-title":"Neurogastroenterol Motil"},{"issue":"6","key":"804_CR51","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH. Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord. 2012;27(6):716\u20139.","journal-title":"Mov Disord"},{"issue":"Pt 3","key":"804_CR52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/brain\/awu369","volume":"138","author":"T Gjerl\u00f8ff","year":"2015","unstructured":"Gjerl\u00f8ff T, Fedorova T, Knudsen K, Munk OL, Nahimi A, Jacobsen S, et al. Imaging acetylcholinesterase density in peripheral organs in Parkinson\u2019s disease with 11\u00a0C-donepezil PET. Brain. 2015;138(Pt 3):653\u201363.","journal-title":"Brain"},{"issue":"8","key":"804_CR53","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","volume":"88","author":"TD Fedorova","year":"2017","unstructured":"Fedorova TD, Seidelin LB, Knudsen K, Schacht AC, Geday J, Pavese N, et al. Decreased intestinal acetylcholinesterase in early Parkinson disease: an (11)C-donepezil PET study. Neurology. 2017;88(8):775\u201381.","journal-title":"Neurology"},{"issue":"4","key":"804_CR54","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3390\/biom12040576","volume":"12","author":"A Srivastava","year":"2022","unstructured":"Srivastava A, Alam P, Caughey B. RT-QuIC and related assays for detecting and quantifying prion-like pathological seeds of \u03b1-Synuclein. Biomolecules. 2022;12(4):576.","journal-title":"Biomolecules"},{"issue":"1","key":"804_CR55","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s40478-022-01388-7","volume":"10","author":"S Hall","year":"2022","unstructured":"Hall S, Orr\u00f9 CD, Serrano GE, Galasko D, Hughson AG, Groveman BR, et al. Performance of \u03b1Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. 2022;10(1):90.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"804_CR56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F, et al. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol. 2024;147(1):18.","journal-title":"Acta Neuropathol"},{"key":"804_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2022.08.012","volume":"103","author":"C Shin","year":"2022","unstructured":"Shin C, Han JY, Kim SI, Park SH, Yang HK, Lee HJ, et al. In vivo and autopsy validation of alpha-synuclein seeding activity using RT-QuIC assay in the gastrointestinal tract of patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2022;103:23\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"804_CR58","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/ana.24448","volume":"78","author":"E Svensson","year":"2015","unstructured":"Svensson E, Horvath-Puho E, Thomsen RW, Djurhuus JC, Pedersen L, Borghammer P, et al. Vagotomy and subsequent risk of Parkinson\u2019s disease. Ann Neurol. 2015;78(4):522\u20139.","journal-title":"Ann Neurol"},{"issue":"21","key":"804_CR59","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/WNL.0000000000003961","volume":"88","author":"B Liu","year":"2017","unstructured":"Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, et al. Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study. Neurology. 2017;88(21):1996\u20132002.","journal-title":"Neurology"},{"issue":"8","key":"804_CR60","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/mds.25779","volume":"29","author":"MT Gray","year":"2014","unstructured":"Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulfe JM. Alpha-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord. 2014;29(8):991\u20138.","journal-title":"Mov Disord"},{"issue":"9","key":"804_CR61","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1002\/mds.109","volume":"33","author":"N Palacios","year":"2018","unstructured":"Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A. Appendectomy and risk of Parkinson\u2019s disease in two large prospective cohorts of men and women. Mov Disord. 2018;33(9):1492\u20136.","journal-title":"Mov Disord"},{"issue":"9","key":"804_CR62","doi-asserted-by":"publisher","first-page":"e2431949","DOI":"10.1001\/jamanetworkopen.2024.31949","volume":"7","author":"JJ Chang","year":"2024","unstructured":"Chang JJ, Kulkarni S, Pasricha TS. Upper gastrointestinal mucosal damage and subsequent risk of Parkinson disease. JAMA Netw Open. 2024;7(9):e2431949.","journal-title":"JAMA Netw Open"},{"issue":"3","key":"804_CR63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.parkreldis.2014.12.009","volume":"21","author":"AH Tan","year":"2015","unstructured":"Tan AH, Mahadeva S, Marras C, Thalha AM, Kiew CK, Yeat CM, et al. Helicobacter pylori infection is associated with worse severity of Parkinson\u2019s disease. Parkinsonism Relat Disord. 2015;21(3):221\u20135.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"804_CR64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3988\/jcn.2016.12.2.147","volume":"12","author":"G \u00c7amc\u0131","year":"2016","unstructured":"\u00c7amc\u0131 G, O\u011fuz S. Association between Parkinson\u2019s disease and helicobacter pylori. J Clin Neurol. 2016;12(2):147\u201350.","journal-title":"J Clin Neurol"},{"issue":"1","key":"804_CR65","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41531-022-00318-7","volume":"8","author":"D Freuer","year":"2022","unstructured":"Freuer D, Meisinger C. Association between inflammatory bowel disease and Parkinson\u2019s disease: a mendelian randomization study. NPJ Parkinsons Dis. 2022;8(1):55.","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"804_CR66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211.","journal-title":"Neurobiol Aging"},{"issue":"s2","key":"804_CR67","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/JPD-191721","volume":"9","author":"P Borghammer","year":"2019","unstructured":"Borghammer P, Van Den Berge N. Brain-first versus gut-first Parkinson\u2019s disease: a hypothesis. J Parkinson\u2019s Dis. 2019;9(s2):S281\u201395.","journal-title":"J Parkinson\u2019s Dis"},{"key":"804_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105557","volume":"161","author":"P Borghammer","year":"2021","unstructured":"Borghammer P, Horsager J, Andersen K, Van Den Berge N, Raunio A, Murayama S, et al. Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol Dis. 2021;161:105557.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"804_CR69","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","volume":"110","author":"H Braak","year":"2003","unstructured":"Braak H, Rub U, Gai WP, Del Tredici K. Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm. 2003;110(5):517\u201336.","journal-title":"J Neural Transm"},{"issue":"2","key":"804_CR70","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/JPD-202481","volume":"11","author":"P Borghammer","year":"2021","unstructured":"Borghammer P. The \u03b1-Synuclein origin and Connectome Model (SOC Model) of Parkinson\u2019s disease: explaining motor asymmetry, non-motor phenotypes, and cognitive decline. J Parkinsons Dis. 2021;11(2):455\u201374.","journal-title":"J Parkinsons Dis"},{"key":"804_CR71","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager J, Borghammer P. Brain-first vs. body-first Parkinson\u2019s disease: an update on recent evidence. Parkinsonism Relat Disord. 2024;122:106101.","journal-title":"Parkinsonism Relat Disord"},{"key":"804_CR72","doi-asserted-by":"publisher","first-page":"102161","DOI":"10.1016\/j.nicl.2019.102161","volume":"25","author":"GN Stormezand","year":"2020","unstructured":"Stormezand GN, Chaves LT, V\u00e1llez Garc\u00eda D, Doorduin J, De Jong BM, Leenders KL, et al. Intrastriatal gradient analyses of 18F-FDOPA PET scans for differentiation of parkinsonian disorders. Neuroimage Clin. 2020;25:102161.","journal-title":"Neuroimage Clin"},{"issue":"1","key":"804_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41531-021-00199-2","volume":"7","author":"F Depierreux","year":"2021","unstructured":"Depierreux F, Parmentier E, Mackels L, Baquero K, Degueldre C, Balteau E, et al. Parkinson\u2019s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI. NPJ Parkinsons Dis. 2021;7(1):57.","journal-title":"NPJ Parkinsons Dis"},{"issue":"Pt 8","key":"804_CR74","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, et al. Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain. 2013;136(Pt 8):2419\u201331.","journal-title":"Brain"},{"issue":"23","key":"804_CR75","doi-asserted-by":"publisher","first-page":"e172192","DOI":"10.1172\/jci.insight.172192","volume":"8","author":"R Chandra","year":"2023","unstructured":"Chandra R, Sokratian A, Chavez KR, King S, Swain SM, Snyder JC, et al. Gut mucosal cells transfer \u03b1-synuclein to the vagus nerve. JCI Insight. 2023;8(23):e172192.","journal-title":"JCI Insight."},{"issue":"31","key":"804_CR76","doi-asserted-by":"publisher","first-page":"12571","DOI":"10.1073\/pnas.0906759106","volume":"106","author":"CW Olanow","year":"2009","unstructured":"Olanow CW, Prusiner SB. Is Parkinson\u2019s disease a prion disorder? Proc Natl Acad Sci U S A. 2009;106(31):12571\u20132.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"804_CR77","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1212\/WNL.0000000000006926","volume":"92","author":"AJ Espay","year":"2019","unstructured":"Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, et al. Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases. Neurology. 2019;92(7):329\u201337.","journal-title":"Neurology"},{"issue":"41","key":"804_CR78","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1523\/JNEUROSCI.1787-16.2017","volume":"37","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM. Parkinson\u2019s disease is not simply a prion disorder. J Neurosci. 2017;37(41):9799\u2013807.","journal-title":"J Neurosci"},{"issue":"1","key":"804_CR79","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","volume":"135","author":"NL Rey","year":"2018","unstructured":"Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ, et al. Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term. Acta Neuropathol. 2018;135(1):65\u201383.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"804_CR80","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski NK, Volpicelli-Daley LA, Sortwell CE, Luk KC, Cremades N, Gottler LM, et al. Best practices for Generating and using alpha-synuclein pre-formed fibrils to Model Parkinson\u2019s disease in rodents. J Parkinsons Di. 2018;8(2):303\u201322.","journal-title":"J Parkinsons Di"},{"issue":"1","key":"804_CR81","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-020-03369-x","volume":"12","author":"JJ Guo","year":"2021","unstructured":"Guo JJ, Yue F, Song DY, Bousset L, Liang X, Tang J, et al. Intranasal administration of \u03b1-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis. Cell Death Dis. 2021;12(1):81.","journal-title":"Cell Death Dis"},{"key":"804_CR82","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"112","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;112:106\u201318.","journal-title":"Neurobiol Dis"},{"issue":"44","key":"804_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq3539","volume":"10","author":"A Sokratian","year":"2024","unstructured":"Sokratian A, Zhou Y, Tatli M, Burbidge KJ, Xu E, Viverette E, et al. Mouse \u03b1-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases. Sci Adv. 2024;10(44):eadq3539.","journal-title":"Sci Adv"},{"issue":"6109","key":"804_CR84","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science. 2012;338(6109):949\u201353.","journal-title":"Science"},{"issue":"4","key":"804_CR85","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3233\/JPD-212847","volume":"11","author":"NK Polinski","year":"2021","unstructured":"Polinski NK. A summary of phenotypes observed in the in vivo rodent alpha-synuclein preformed fibril model. J Parkinsons Di. 2021;11(4):1555\u201367.","journal-title":"J Parkinsons Di"},{"issue":"1","key":"804_CR86","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40478-018-0587-0","volume":"6","author":"A Okuzumi","year":"2018","unstructured":"Okuzumi A, Kurosawa M, Hatano T, Takanashi M, Nojiri S, Fukuhara T, et al. Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment. Acta Neuropathol Commun. 2018;6(1):96.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"804_CR87","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara T, Giasson BI. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 2016;131(1):49\u201373.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"804_CR88","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1080\/19336896.2016.1223003","volume":"10","author":"S Abounit","year":"2016","unstructured":"Abounit S, Wu JW, Duff K, Victoria GS, Zurzolo C. Tunneling nanotubes: a possible highway in the spreading of tau and other prion-like proteins in neurodegenerative diseases. Prion. 2016;10(5):344\u201351.","journal-title":"Prion"},{"issue":"4","key":"804_CR89","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-016-1538-0","volume":"131","author":"M Brahic","year":"2016","unstructured":"Brahic M, Bousset L, Bieri G, Melki R, Gitler AD. Axonal transport and secretion of fibrillar forms of \u03b1-synuclein, A\u03b242 peptide and HTTExon 1. Acta Neuropathol. 2016;131(4):539\u201348.","journal-title":"Acta Neuropathol"},{"issue":"24","key":"804_CR90","doi-asserted-by":"publisher","first-page":"22670","DOI":"10.1074\/jbc.M501508200","volume":"280","author":"CW Liu","year":"2005","unstructured":"Liu CW, Giasson BI, Lewis KA, Lee VM, Demartino GN, Thomas PJ. A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease. J Biol Chem. 2005;280(24):22670\u20138.","journal-title":"J Biol Chem"},{"issue":"21","key":"804_CR91","doi-asserted-by":"publisher","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","volume":"288","author":"SA Tanik","year":"2013","unstructured":"Tanik SA, Schultheiss CE, Volpicelli-Daley LA, Brunden KR, Lee VM. Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy. J Biol Chem. 2013;288(21):15194\u2013210.","journal-title":"J Biol Chem"},{"issue":"20","key":"804_CR92","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","volume":"30","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Melachroinou K, Roumeliotis T, Garbis SD, Ntzouni M, Margaritis LH, et al. Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J Neurosci. 2010;30(20):6838\u201351.","journal-title":"J Neurosci"},{"key":"804_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegeneration. 2012;7:42.","journal-title":"Mol Neurodegeneration"},{"key":"804_CR94","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.brainres.2015.06.047","volume":"1622","author":"AF Cintron","year":"2015","unstructured":"Cintron AF, Dalal NV, Dooyema J, Betarbet R, Walker LC. Transport of cargo from periphery to brain by circulating monocytes. Brain Res. 2015;1622:328\u201338.","journal-title":"Brain Res"},{"issue":"6","key":"804_CR95","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Del Tredici","year":"2010","unstructured":"Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol. 2010;119(6):703\u201313.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"804_CR96","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-008-0355-5","volume":"115","author":"K Del Tredici","year":"2008","unstructured":"Del Tredici K, Braak H. A not entirely benign procedure: progression of Parkinson\u2019s disease. Acta Neuropathol. 2008;115(4):379\u201384.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"804_CR97","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/BF00369454","volume":"86","author":"S Takeda","year":"1993","unstructured":"Takeda S, Yamazaki K, Miyakawa T, Arai H. Parkinson\u2019s disease with involvement of the parasympathetic ganglia. Acta Neuropathol. 1993;86(4):397\u20138.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"804_CR98","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1212\/WNL.42.11.2106","volume":"42","author":"WP Gai","year":"1992","unstructured":"Gai WP, Blumbergs PC, Geffen LB, Blessing WW. Age-related loss of dorsal vagal neurons in Parkinson\u2019s disease. Neurology. 1992;42(11):2106\u201311.","journal-title":"Neurology"},{"issue":"5","key":"804_CR99","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol. 2002;61(5):413\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"804_CR100","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol. 2006;32(3):284\u201395.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"1","key":"804_CR101","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.expneurol.2007.07.006","volume":"209","author":"GM Halliday","year":"2008","unstructured":"Halliday GM, McCann H. Human-based studies on alpha-synuclein deposition and relationship to Parkinson\u2019s disease symptoms. Exp Neurol. 2008;209(1):12\u201321.","journal-title":"Exp Neurol"},{"issue":"7","key":"804_CR102","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/NEN.0b013e3182965886","volume":"72","author":"L Mu","year":"2013","unstructured":"Mu L, Sobotka S, Chen J, Su H, Sanders I, Nyirenda T, et al. Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol. 2013;72(7):614\u201323.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"804_CR103","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","volume":"23","author":"C Challis","year":"2020","unstructured":"Challis C, Hori A, Sampson TR, Yoo BB, Challis RC, Hamilton AM, et al. Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice. Nat Neurosci. 2020;23(3):327\u201336.","journal-title":"Nat Neurosci"},{"issue":"6","key":"804_CR104","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128(6):805\u201320.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"804_CR105","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138(4):535\u201350.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"804_CR106","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00418-018-1746-x","volume":"150","author":"LJ Fothergill","year":"2018","unstructured":"Fothergill LJ, Furness JB. Diversity of enteroendocrine cells investigated at cellular and subcellular levels: the need for a new classification scheme. Histochem Cell Biol. 2018;150(6):693\u2013702.","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"804_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089881","volume":"9","author":"DV Bohorquez","year":"2014","unstructured":"Bohorquez DV, Samsa LA, Roholt A, Medicetty S, Chandra R, Liddle RA. An enteroendocrine cell-enteric glia connection revealed by 3D electron microscopy. PLoS ONE. 2014;9(2):e89881.","journal-title":"PLoS ONE"},{"issue":"2","key":"804_CR108","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1172\/JCI78361","volume":"125","author":"DV Bohorquez","year":"2015","unstructured":"Bohorquez DV, Shahid RA, Erdmann A, Kreger AM, Wang Y, Calakos N, et al. Neuroepithelial circuit formed by innervation of sensory enteroendocrine cells. J Clin Invest. 2015;125(2):782\u20136.","journal-title":"J Clin Invest"},{"issue":"6408","key":"804_CR109","doi-asserted-by":"publisher","first-page":"eaat5236","DOI":"10.1126\/science.aat5236","volume":"361","author":"MM Kaelberer","year":"2018","unstructured":"Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, Shen X, et al. A gut-brain neural circuit for nutrient sensory transduction. Science. 2018;361(6408):eaat5236.","journal-title":"Science"},{"issue":"2","key":"804_CR110","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41593-021-00982-7","volume":"25","author":"KL Buchanan","year":"2022","unstructured":"Buchanan KL, Rupprecht LE, Kaelberer MM, Sahasrabudhe A, Klein ME, Villalobos JA, et al. The preference for sugar over sweetener depends on a gut sensor cell. Nat Neurosci. 2022;25(2):191\u2013200.","journal-title":"Nat Neurosci"},{"issue":"12","key":"804_CR111","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrgastro.2013.180","volume":"10","author":"JB Furness","year":"2013","unstructured":"Furness JB, Rivera LR, Cho HJ, Bravo DM, Callaghan B. The gut as a sensory organ. Nat Rev Gastroenterol Hepatol. 2013;10(12):729\u201340.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"804_CR112","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1016\/j.cell.2020.04.036","volume":"181","author":"J Beumer","year":"2020","unstructured":"Beumer J, Puschhof J, Bauz\u00e1-Martinez J, Mart\u00ednez-Silgado A, Elmentaite R, James KR, et al. High-resolution mRNA and Secretome Atlas of Human Enteroendocrine cells. Cell. 2020;181(6):1291\u2013e30619.","journal-title":"Cell"},{"issue":"6","key":"804_CR113","doi-asserted-by":"publisher","first-page":"e90638","DOI":"10.1371\/journal.pone.0090638","volume":"9","author":"T Nagatake","year":"2014","unstructured":"Nagatake T, Fujita H, Minato N, Hamazaki Y. Enteroendocrine cells are specifically marked by cell surface expression of claudin-4 in mouse small intestine. PLoS ONE. 2014;9(6):e90638.","journal-title":"PLoS ONE"},{"issue":"12","key":"804_CR114","doi-asserted-by":"publisher","first-page":"e92295","DOI":"10.1172\/jci.insight.92295","volume":"2","author":"R Chandra","year":"2017","unstructured":"Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA. Alpha-Synuclein in gut endocrine cells and its implications for Parkinson\u2019s disease. JCI Insight. 2017;2(12):e92295.","journal-title":"JCI Insight."},{"issue":"8","key":"804_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016;14(8):e1002533.","journal-title":"PLoS Biol"},{"issue":"1","key":"804_CR116","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1038\/s41467-022-31502-1","volume":"13","author":"S Leviatan","year":"2022","unstructured":"Leviatan S, Shoer S, Rothschild D, Gorodetski M, Segal E. An expanded reference map of the human gut microbiome reveals hundreds of previously unknown species. Nat Commun. 2022;13(1):3863.","journal-title":"Nat Commun"},{"issue":"7","key":"804_CR117","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/nn.4030","volume":"18","author":"D Erny","year":"2015","unstructured":"Erny D, Hrab\u011b de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci. 2015;18(7):965\u201377.","journal-title":"Nat Neurosci"},{"issue":"2","key":"804_CR118","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nn.4476","volume":"20","author":"TC Fung","year":"2017","unstructured":"Fung TC, Olson CA, Hsiao EY. Interactions between the microbiota, immune and nervous systems in health and disease. Nat Neurosci. 2017;20(2):145\u201355.","journal-title":"Nat Neurosci"},{"issue":"4","key":"804_CR119","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21(4):236\u201347.","journal-title":"Nat Rev Microbiol"},{"key":"804_CR120","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","volume":"89","author":"GC Hansson","year":"2020","unstructured":"Hansson GC. Mucins and the microbiome. Annu Rev Biochem. 2020;89:769\u201393.","journal-title":"Annu Rev Biochem"},{"issue":"2","key":"804_CR121","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161(2):264\u201376.","journal-title":"Cell"},{"issue":"5","key":"804_CR122","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.cmet.2014.10.016","volume":"20","author":"G Sharon","year":"2014","unstructured":"Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell Metab. 2014;20(5):719\u201330.","journal-title":"Cell Metab"},{"issue":"4","key":"804_CR123","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.cell.2016.10.027","volume":"167","author":"G Sharon","year":"2016","unstructured":"Sharon G, Sampson TR, Geschwind DH, Mazmanian SK. The central nervous system and the gut microbiome. Cell. 2016;167(4):915\u201332.","journal-title":"Cell"},{"issue":"3","key":"804_CR124","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/mds.29300","volume":"38","author":"JC Boktor","year":"2023","unstructured":"Boktor JC, Sharon G, Verhagen Metman LA, Hall DA, Engen PA, Zreloff Z, et al. Integrated multi-cohort analysis of the Parkinson\u2019s disease gut metagenome. Mov Disord. 2023;38(3):399\u2013409.","journal-title":"Mov Disord"},{"issue":"1","key":"804_CR125","doi-asserted-by":"publisher","first-page":"6958","DOI":"10.1038\/s41467-022-34667-x","volume":"13","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD, Demirkan A, Twa G, Cohen G, Dean MN, Standaert DG, et al. Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun. 2022;13(1):6958.","journal-title":"Nat Commun"},{"issue":"8","key":"804_CR126","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen SJ, Chen CC, Liao HY, Lin YT, Wu YW, Liou JM, et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology. 2022;98(8):e848\u201358.","journal-title":"Neurology"},{"issue":"3","key":"804_CR127","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/ana.26719","volume":"94","author":"N Palacios","year":"2023","unstructured":"Palacios N, Wilkinson J, Bjornevik K, Schwarzschild MA, McIver L, Ascherio A, et al. Metagenomics of the gut microbiome in Parkinson\u2019s disease: prodromal changes. Ann Neurol. 2023;94(3):486\u2013501.","journal-title":"Ann Neurol"},{"key":"804_CR128","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho VTE, Pereira PAB, Voutilainen S, Paulin L, Pekkonen E, Auvinen P, et al. Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine. 2019;44:691\u2013707.","journal-title":"EBioMedicine"},{"issue":"1","key":"804_CR129","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00427-6","volume":"16","author":"VTE Aho","year":"2021","unstructured":"Aho VTE, Houser MC, Pereira PAB, Chang J, Rudi K, Paulin L, et al. Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease. Mol Neurodegeneration. 2021;16(1):6.","journal-title":"Mol Neurodegeneration"},{"key":"804_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108806","volume":"190","author":"Z Deng","year":"2024","unstructured":"Deng Z, Li L, Jing Z, Luo X, Yu F, Zeng W, et al. Association between environmental phthalates exposure and gut microbiota and metabolome in dementia with Lewy bodies. Environ Int. 2024;190:108806.","journal-title":"Environ Int"},{"issue":"1","key":"804_CR131","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41531-022-00428-2","volume":"8","author":"H Nishiwaki","year":"2022","unstructured":"Nishiwaki H, Ueyama J, Kashihara K, Ito M, Hamaguchi T, Maeda T, et al. Gut microbiota in dementia with Lewy bodies. NPJ Parkinsons Dis. 2022;8(1):169.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"804_CR132","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41531-021-00244-0","volume":"7","author":"S Weis","year":"2021","unstructured":"Weis S, Meisner A, Schwiertz A, Unger MM, Becker A, Fa\u00dfbender K, et al. Association between Parkinson\u2019s disease and the faecal eukaryotic microbiota. NPJ Parkinsons Dis. 2021;7(1):101.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"804_CR133","doi-asserted-by":"publisher","first-page":"10812","DOI":"10.1038\/s41598-018-29173-4","volume":"8","author":"G Tetz","year":"2018","unstructured":"Tetz G, Brown SM, Hao Y, Tetz V. Parkinson\u2019s disease and bacteriophages as its overlooked contributors. Sci Rep. 2018;8(1):10812.","journal-title":"Sci Rep"},{"issue":"1","key":"804_CR134","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3233\/JPD-202237","volume":"11","author":"MS Cirstea","year":"2021","unstructured":"Cirstea MS, Sundvick K, Golz E, Yu AC, Boutin RCT, Kliger D, et al. The gut mycobiome in Parkinson\u2019s disease. J Parkinsons Di. 2021;11(1):153\u20138.","journal-title":"J Parkinsons Di"},{"issue":"1","key":"804_CR135","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med. 2017;9(1):39.","journal-title":"Genome Med"},{"issue":"6","key":"804_CR136","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mSystems.00797-20","volume":"5","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, et al. Short-Chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder. mSystems. 2020;5(6):10.","journal-title":"mSystems"},{"issue":"1","key":"804_CR137","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/s41467-023-38248-4","volume":"14","author":"B Huang","year":"2023","unstructured":"Huang B, Chau SWH, Liu Y, Chan JWY, Wang J, Ma SL, et al. Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives. Nat Commun. 2023;14(1):2501.","journal-title":"Nat Commun"},{"key":"804_CR138","doi-asserted-by":"crossref","unstructured":"Krueger ME, Boles JS, Simon ZD, Alvarez SD, McFarland NR, Okun MS, et al. A comparative analysis of Parkinson\u2019s disease and inflammatory bowel disease gut microbiomes highlights shared depletions in key butyrate-producing bacteria. bioRxiv. 2024.04.26.591350.","DOI":"10.1101\/2024.04.26.591350"},{"issue":"6","key":"804_CR139","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/brainsci12060739","volume":"12","author":"R Cerroni","year":"2022","unstructured":"Cerroni R, Pietrucci D, Teofani A, Chillemi G, Liguori C, Pierantozzi M, et al. Not just a snapshot: an Italian longitudinal evaluation of stability of gut microbiota findings in Parkinson\u2019s disease. Brain Sci. 2022;12(6):739.","journal-title":"Brain Sci"},{"issue":"1","key":"804_CR140","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-022-00328-5","volume":"8","author":"H Nishiwaki","year":"2022","unstructured":"Nishiwaki H, Ito M, Hamaguchi T, Maeda T, Kashihara K, Tsuboi Y, et al. Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):65.","journal-title":"NPJ Parkinsons Dis"},{"key":"804_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.875261","volume":"14","author":"M Lubomski","year":"2022","unstructured":"Lubomski M, Xu X, Holmes AJ, Muller S, Yang JYH, Davis RL, et al. The gut microbiome in Parkinson\u2019s disease: a longitudinal study of the impacts on disease progression and the use of device-assisted therapies. Front Aging Neurosci. 2022;14:875261.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"804_CR142","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord. 2017;32(5):739\u201349.","journal-title":"Mov Disord"},{"issue":"8","key":"804_CR143","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian Y, Yang X, Xu S, Huang P, Li B, Du J, et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain. 2020;143(8):2474\u201389.","journal-title":"Brain"},{"key":"804_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.728479","volume":"12","author":"L Mao","year":"2021","unstructured":"Mao L, Zhang Y, Tian J, Sang M, Zhang G, Zhou Y, et al. Cross-sectional study on the gut microbiome of Parkinson\u2019s disease patients in Central China. Front Microbiol. 2021;12:728479.","journal-title":"Front Microbiol"},{"issue":"1","key":"804_CR145","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41531-022-00351-6","volume":"8","author":"S Jo","year":"2022","unstructured":"Jo S, Kang W, Hwang YS, Lee SH, Park KW, Kim MS, et al. Oral and gut dysbiosis leads to functional alterations in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2022;8(1):87.","journal-title":"NPJ Parkinsons Dis"},{"issue":"6","key":"804_CR146","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell. 2016;167(6):1469\u201380.","journal-title":"Cell"},{"issue":"5","key":"804_CR147","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3233\/JPD-223165","volume":"12","author":"N Radisavljevic","year":"2022","unstructured":"Radisavljevic N, Cirstea M, Bauer K, Lo C, Metcalfe-Roach A, Bozorgmehr T, et al. Effects of Gut Microbiota alterations on motor, gastrointestinal, and behavioral phenotype in a mouse model of Parkinson\u2019s disease. J Parkinson\u2019s Dis. 2022;12(5):1479\u201395.","journal-title":"J Parkinson\u2019s Dis"},{"issue":"1","key":"804_CR148","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1866974","volume":"13","author":"Y Bhattarai","year":"2021","unstructured":"Bhattarai Y, Si J, Pu M, Ross OA, McLean PJ, Till L, et al. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson\u2019s disease. Gut Microbes. 2021;13(1):1866974.","journal-title":"Gut Microbes"},{"issue":"6","key":"804_CR149","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.14336\/AD.2023.0309","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie Z, Zhang M, Luo Y, Jin D, Guo X, Yang W, et al. Healthy human fecal microbiota transplantation into mice attenuates MPTP-Induced neurotoxicity via AMPK\/SOD2 pathway. Aging Dis. 2023;14(6):2193\u2013214.","journal-title":"Aging Dis"},{"key":"804_CR150","first-page":"34","volume":"118","author":"C Wang","year":"2021","unstructured":"Wang C, Lau CY, Ma F, Zheng C. Genome-wide screen identifies curli amyloid fibril as a bacterial component promoting host neurodegeneration. Proc Natl Acad Sci U S A. 2021;118:34.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"804_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113071","volume":"42","author":"KJ Schmit","year":"2023","unstructured":"Schmit KJ, Garcia P, Sciortino A, Aho VTE, Pardo Rodriguez B, Thomas MH, et al. Fiber deprivation and microbiome-borne curli shift gut bacterial populations and accelerate disease in a mouse model of Parkinson\u2019s disease. Cell Rep. 2023;42(9):113071.","journal-title":"Cell Rep"},{"key":"804_CR152","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7554\/eLife.53111","volume":"9","author":"TR Sampson","year":"2020","unstructured":"Sampson TR, Challis C, Jain N, Moiseyenko A, Ladinsky MS, Shastri GG, et al. A gut bacterial amyloid promotes alpha-synuclein aggregation and motor impairment in mice. Elife. 2020;9:9.","journal-title":"Elife."},{"issue":"5","key":"804_CR153","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00401-023-02562-4","volume":"145","author":"W Peelaerts","year":"2023","unstructured":"Peelaerts W, Mercado G, George S, Villumsen M, Kasen A, Aguileta M, et al. Urinary tract infections trigger synucleinopathy via the innate immune response. Acta Neuropathol. 2023;145(5):541\u201359.","journal-title":"Acta Neuropathol"},{"key":"804_CR154","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17023","author":"T Sampson","year":"2023","unstructured":"Sampson T. Microbial amyloids in neurodegenerative amyloid diseases. FEBS J. 2023. https:\/\/doi.org\/10.1111\/febs.17023.","journal-title":"FEBS J"},{"issue":"3","key":"804_CR155","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord. 2015;30(3):350\u20138.","journal-title":"Mov Disord"},{"issue":"12","key":"804_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006654","volume":"13","author":"RP Friedland","year":"2017","unstructured":"Friedland RP, Chapman MR. The role of microbial amyloid in neurodegeneration. PLoS Pathog. 2017;13(12):e1006654.","journal-title":"PLoS Pathog"},{"key":"804_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/srep34477","volume":"6","author":"SG Chen","year":"2016","unstructured":"Chen SG, Stribinskis V, Rane MJ, Demuth DR, Gozal E, Roberts AM, et al. Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and caenorhabditis elegans. Sci Rep. 2016;6:34477.","journal-title":"Sci Rep"},{"issue":"7","key":"804_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.102088","volume":"298","author":"SS Bhoite","year":"2022","unstructured":"Bhoite SS, Han Y, Ruotolo BT, Chapman MR. Mechanistic insights into accelerated \u03b1-synuclein aggregation mediated by human microbiome-associated functional amyloids. J Biol Chem. 2022;298(7):102088.","journal-title":"J Biol Chem"},{"issue":"1","key":"804_CR159","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1038\/s41467-024-48309-x","volume":"15","author":"A Fern\u00e1ndez-Calvet","year":"2024","unstructured":"Fern\u00e1ndez-Calvet A, Matilla-Cuenca L, Izco M, Navarro S, Serrano M, Ventura S, et al. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration. Nat Commun. 2024;15(1):4150.","journal-title":"Nat Commun"},{"issue":"6","key":"804_CR160","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/febs.17027","volume":"291","author":"JR Monteiro Neto","year":"2024","unstructured":"Monteiro Neto JR, Lima VA, Follmer C. Fibrillation of \u03b1-synuclein triggered by bacterial endotoxin and lipid vesicles is modulated by N-terminal acetylation and familial Parkinson\u2019s disease mutations. Febs j. 2024;291(6):1151\u201367.","journal-title":"Febs j"},{"issue":"1","key":"804_CR161","doi-asserted-by":"publisher","first-page":"5382","DOI":"10.1038\/s41467-021-25767-1","volume":"12","author":"D Dutta","year":"2021","unstructured":"Dutta D, Jana M, Majumder M, Mondal S, Roy A, Pahan K. Selective targeting of the TLR2\/MyD88\/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo. Nat Commun. 2021;12(1):5382.","journal-title":"Nat Commun"},{"issue":"3","key":"804_CR162","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, et al. Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia. 2013;61(3):349\u201360.","journal-title":"Glia"},{"issue":"1","key":"804_CR163","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s40478-020-00988-5","volume":"8","author":"C Mez\u00f6","year":"2020","unstructured":"Mez\u00f6 C, Dokalis N, Mossad O, Staszewski O, Neuber J, Yilmaz B, et al. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer\u2019s disease. Acta Neuropathol Commun. 2020;8(1):119.","journal-title":"Acta Neuropathol Commun"},{"issue":"8","key":"804_CR164","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/mds.29128","volume":"37","author":"A Xie","year":"2022","unstructured":"Xie A, Ensink E, Li P, Gordevi\u010dius J, Marshall LL, George S, et al. Bacterial butyrate in Parkinson\u2019s disease is linked to epigenetic changes and depressive symptoms. Mov Disord. 2022;37(8):1644\u201353.","journal-title":"Mov Disord"},{"issue":"2","key":"804_CR165","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.gpb.2021.08.009","volume":"20","author":"A Becker","year":"2022","unstructured":"Becker A, Schmartz GP, Gr\u00f6ger L, Grammes N, Galata V, Philippeit H, et al. Effects of resistant starch on symptoms, fecal markers, and gut microbiota in Parkinson\u2019s Disease - The RESISTA-PD Trial. Genomics Proteom Bioinf. 2022;20(2):274\u201387.","journal-title":"Genomics Proteom Bioinf"},{"issue":"1","key":"804_CR166","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41467-023-36497-x","volume":"14","author":"DA Hall","year":"2023","unstructured":"Hall DA, Voigt RM, Cantu-Jungles TM, Hamaker B, Engen PA, Shaikh M, et al. An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson\u2019s disease participants. Nat Commun. 2023;14(1):926.","journal-title":"Nat Commun"},{"key":"804_CR167","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7554\/eLife.81453","volume":"11","author":"R Abdel-Haq","year":"2022","unstructured":"Abdel-Haq R, Schlachetzki JCM, Boktor JC, Cantu-Jungles TM, Thron T, Zhang M, et al. A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice. Elife. 2022;11:11.","journal-title":"Elife."},{"issue":"1","key":"804_CR168","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s40572-016-0083-2","volume":"3","author":"BR Ritz","year":"2016","unstructured":"Ritz BR, Paul KC, Bronstein JM. Of pesticides and men: a California Story of genes and environment in Parkinson\u2019s Disease. Curr Environ Health Rep. 2016;3(1):40\u201352.","journal-title":"Curr Environ Health Rep"},{"issue":"1","key":"804_CR169","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41531-023-00603-z","volume":"9","author":"H Payami","year":"2023","unstructured":"Payami H, Cohen G, Murchison CF, Sampson TR, Standaert DG, Wallen ZD. Population fraction of Parkinson\u2019s disease attributable to preventable risk factors. NPJ Parkinsons Dis. 2023;9(1):159.","journal-title":"NPJ Parkinsons Dis"},{"issue":"1","key":"804_CR170","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41531-024-00709-y","volume":"10","author":"BL Santos-Lobato","year":"2024","unstructured":"Santos-Lobato BL. Towards a methodological uniformization of environmental risk studies in Parkinson\u2019s disease. NPJ Parkinsons Dis. 2024;10(1):86.","journal-title":"NPJ Parkinsons Dis"},{"issue":"7762","key":"804_CR171","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M, Zimmermann-Kogadeeva M, Wegmann R, Goodman AL. Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature. 2019;570(7762):462\u20137.","journal-title":"Nature"},{"issue":"25","key":"804_CR172","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson\u2019s disease. Proc Natl Acad Sci U S A. 2001;98(25):14669\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"804_CR173","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neuro.2014.05.009","volume":"44","author":"R Bisht","year":"2014","unstructured":"Bisht R, Kaur B, Gupta H, Prakash A. Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson\u2019s disease in rats. Neurotoxicology. 2014;44:71\u20139.","journal-title":"Neurotoxicology"},{"issue":"2","key":"804_CR174","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pathophys.2017.02.001","volume":"24","author":"B Kaur","year":"2017","unstructured":"Kaur B, Prakash A. Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats. Pathophysiology. 2017;24(2):71\u20139.","journal-title":"Pathophysiology"},{"issue":"17","key":"804_CR175","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.18632\/aging.102221","volume":"11","author":"Y Pu","year":"2019","unstructured":"Pu Y, Chang L, Qu Y, Wang S, Zhang K, Hashimoto K. Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain. Aging. 2019;11(17):6915\u201329.","journal-title":"Aging"},{"key":"804_CR176","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1223120","volume":"14","author":"MFB Gois","year":"2023","unstructured":"Gois MFB, Fern\u00e1ndez-Pato A, Huss A, Gacesa R, Wijmenga C, Weersma RK, et al. Impact of occupational pesticide exposure on the human gut microbiome. Front Microbiol. 2023;14:1223120.","journal-title":"Front Microbiol"},{"key":"804_CR177","doi-asserted-by":"publisher","first-page":"116176","DOI":"10.1016\/j.taap.2022.116176","volume":"451","author":"NM Ilieva","year":"2022","unstructured":"Ilieva NM, Wallen ZD, De Miranda BR. Oral ingestion of the environmental toxicant trichloroethylene in rats induces alterations in the gut microbiome: relevance to idiopathic Parkinson\u2019s disease. Toxicol Appl Pharmacol. 2022;451:116176.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"804_CR178","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172914","volume":"12","author":"F Alhasson","year":"2017","unstructured":"Alhasson F, Das S, Seth R, Dattaroy D, Chandrashekaran V, Ryan CN, et al. Altered gut microbiome in a mouse model of Gulf War illness causes neuroinflammation and intestinal injury via leaky gut and TLR4 activation. PLoS ONE. 2017;12(3):e0172914.","journal-title":"PLoS ONE"},{"issue":"6","key":"804_CR179","doi-asserted-by":"publisher","first-page":"101581","DOI":"10.1016\/j.xcrm.2024.101581","volume":"5","author":"S Krause","year":"2024","unstructured":"Krause S, Ouellet V, Allen D, Allen S, Moss K, Nel HA, et al. The potential of micro- and nanoplastics to exacerbate the health impacts and global burden of non-communicable diseases. Cell Rep Med. 2024;5(6):101581.","journal-title":"Cell Rep Med"},{"issue":"6550","key":"804_CR180","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1126\/science.abb0354","volume":"373","author":"A Stubbins","year":"2021","unstructured":"Stubbins A, Law KL, Mu\u00f1oz SE, Bianchi TS, Zhu L. Plastics in the Earth system. Science. 2021;373(6550):51\u20135.","journal-title":"Science"},{"issue":"46","key":"804_CR181","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adi8716","volume":"9","author":"Z Liu","year":"2023","unstructured":"Liu Z, Sokratian A, Duda AM, Xu E, Stanhope C, Fu A, et al. Anionic nanoplastic contaminants promote Parkinson\u2019s disease-associated \u03b1-synuclein aggregation. Sci Adv. 2023;9(46):eadi8716.","journal-title":"Sci Adv"},{"issue":"4","key":"804_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112346","volume":"42","author":"Q Yang","year":"2023","unstructured":"Yang Q, Dai H, Cheng Y, Wang B, Xu J, Zhang Y, et al. Oral feeding of nanoplastics affects brain function of mice by inducing macrophage IL-1 signal in the intestine. Cell Rep. 2023;42(4):112346.","journal-title":"Cell Rep"},{"issue":"9","key":"804_CR183","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.immuni.2022.08.005","volume":"55","author":"M Delfini","year":"2022","unstructured":"Delfini M, Stakenborg N, Viola MF, Boeckxstaens G. Macrophages in the gut: masters in multitasking. Immunity. 2022;55(9):1530\u201348.","journal-title":"Immunity"},{"issue":"2","key":"804_CR184","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.07.048","volume":"175","author":"S De Schepper","year":"2018","unstructured":"De Schepper S, Verheijden S, Aguilera-Lizarraga J, Viola MF, Boesmans W, Stakenborg N, et al. Self-maintaining gut macrophages are essential for intestinal homeostasis. Cell. 2018;175(2):400\u2013e1513.","journal-title":"Cell"},{"issue":"7966","key":"804_CR185","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41586-023-06200-7","volume":"618","author":"MF Viola","year":"2023","unstructured":"Viola MF, Chavero-Pieres M, Modave E, Delfini M, Stakenborg N, Est\u00e9vez MC, et al. Dedicated macrophages organize and maintain the enteric nervous system. Nature. 2023;618(7966):818\u201326.","journal-title":"Nature"},{"issue":"8","key":"804_CR186","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1097\/MIB.0000000000000824","volume":"22","author":"ST Gren","year":"2016","unstructured":"Gren ST, Grip O. Role of monocytes and intestinal macrophages in Crohn\u2019s Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016;22(8):1992\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"804_CR187","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1189\/jlb.0113021","volume":"95","author":"S Thiesen","year":"2014","unstructured":"Thiesen S, Janciauskiene S, Uronen-Hansson H, Agace W, H\u00f6gerkorp CM, Spee P, et al. CD14(hi)HLA-DR(dim) macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn\u2019s disease. J Leukoc Biol. 2014;95(3):531\u201341.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"804_CR188","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ibd\/izab031","volume":"28","author":"A Anderson","year":"2022","unstructured":"Anderson A, Cherfane C, Click B, Ramos-Rivers C, Koutroubakis IE, Hashash JG, et al. Monocytosis is a biomarker of severity in inflammatory bowel disease: analysis of a 6-Year prospective natural history registry. Inflamm Bowel Dis. 2022;28(1):70\u20138.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"804_CR189","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, et al. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019;50(2):432 \u2013\u200945.e7.","journal-title":"Immunity"},{"issue":"4","key":"804_CR190","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","volume":"16","author":"BB Williams","year":"2014","unstructured":"Williams BB, Van Benschoten AH, Cimermancic P, Donia MS, Zimmermann M, Taketani M, et al. Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine. Cell Host Microbe. 2014;16(4):495\u2013503.","journal-title":"Cell Host Microbe"},{"issue":"13","key":"804_CR191","doi-asserted-by":"publisher","first-page":"6737","DOI":"10.3390\/ijms22136737","volume":"22","author":"T Behl","year":"2021","unstructured":"Behl T, Kaur I, Sehgal A, Singh S, Bhatia S, Al-Harrasi A, et al. The footprint of Kynurenine pathway in neurodegeneration: Janus-Faced role in Parkinson\u2019s disorder and therapeutic implications. Int J Mol Sci. 2021;22(13):6737.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"804_CR192","doi-asserted-by":"publisher","first-page":"853","DOI":"10.3390\/ijms25020853","volume":"25","author":"S Pathak","year":"2024","unstructured":"Pathak S, Nadar R, Kim S, Liu K, Govindarajulu M, Cook P, et al. The influence of Kynurenine metabolites on neurodegenerative pathologies. Int J Mol Sci. 2024;25(2):853.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"804_CR193","doi-asserted-by":"publisher","first-page":"e02481","DOI":"10.1128\/mBio.02481-14","volume":"6","author":"KA Romano","year":"2015","unstructured":"Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6(2):e02481.","journal-title":"mBio"},{"issue":"6","key":"804_CR194","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nm.4102","volume":"22","author":"B Lamas","year":"2016","unstructured":"Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, et al. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nat Med. 2016;22(6):598\u2013605.","journal-title":"Nat Med"},{"issue":"1","key":"804_CR195","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","volume":"22","author":"M Wlodarska","year":"2017","unstructured":"Wlodarska M, Luo C, Kolde R, d\u2019Hennezel E, Annand JW, Heim CE, et al. Indoleacrylic Acid produced by Commensal Peptostreptococcus Species suppresses inflammation. Cell Host Microbe. 2017;22(1):25\u2013e376.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"804_CR196","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic alpha-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103(4):627\u201341 e7.","journal-title":"Neuron"},{"key":"804_CR197","doi-asserted-by":"crossref","unstructured":"Mackie PM, Koshy J, Bhogade M, Hammoor T, Hachmeister W, Lloyd GM, et al. Complement C1q-dependent engulfment of alpha-synuclein induces ENS-resident macrophage exhaustion and accelerates Parkinson\u2019s-like gut pathology. bioRxiv. 2023.10.24.563832.","DOI":"10.1101\/2023.10.24.563832"},{"issue":"2","key":"804_CR198","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.celrep.2019.09.002","volume":"29","author":"D Duc","year":"2019","unstructured":"Duc D, Vigne S, Bernier-Latmani J, Yersin Y, Ruiz F, Ga\u00efa N, et al. Disrupting myelin-specific Th17 cell gut homing confers Protection in an adoptive transfer experimental autoimmune encephalomyelitis. Cell Rep. 2019;29(2):378\u2013e904.","journal-title":"Cell Rep"},{"issue":"30","key":"804_CR199","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2302697120","volume":"120","author":"IJ Bauer","year":"2023","unstructured":"Bauer IJ, Fang P, L\u00e4mmle KF, Tyystj\u00e4rvi S, Alterauge D, Baumjohann D, et al. Visualizing the activation of encephalitogenic T cells in the ileal lamina propria by in vivo two-photon imaging. Proc Natl Acad Sci U S A. 2023;120(30):e2302697120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"804_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02779","volume":"10","author":"KL Monaghan","year":"2019","unstructured":"Monaghan KL, Zheng W, Hu G, Wan ECK. Monocytes and monocyte-derived Antigen-presenting cells have distinct gene signatures in experimental model of multiple sclerosis. Front Immunol. 2019;10:2779.","journal-title":"Front Immunol"},{"issue":"21","key":"804_CR201","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1016\/j.neuron.2023.07.015","volume":"111","author":"F Garretti","year":"2023","unstructured":"Garretti F, Monahan C, Sloan N, Bergen J, Shahriar S, Kim SW, et al. Interaction of an \u03b1-synuclein epitope with HLA-DRB1(\u2217)15:01 triggers enteric features in mice reminiscent of prodromal Parkinson\u2019s disease. Neuron. 2023;111(21):3397\u2013e4135.","journal-title":"Neuron"},{"issue":"7660","key":"804_CR202","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature22815","volume":"546","author":"D Sulzer","year":"2017","unstructured":"Sulzer D, Alcalay RN, Garretti F, Cote L, Kanter E, Agin-Liebes J, et al. T cells from patients with Parkinson\u2019s disease recognize \u03b1-synuclein peptides. Nature. 2017;546(7660):656\u201361.","journal-title":"Nature"},{"key":"804_CR203","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","volume":"95","author":"M Rojas","year":"2018","unstructured":"Rojas M, Restrepo-Jim\u00e9nez P, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Ram\u00edrez-Santana C, et al. Molecular mimicry and autoimmunity. J Autoimmun. 2018;95:100\u201323.","journal-title":"J Autoimmun"},{"issue":"6","key":"804_CR204","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00476","volume":"21","author":"AR Merchak","year":"2024","unstructured":"Merchak AR, Bolen ML, Tansey MG, Menees KB. Thinking outside the brain: gut microbiome influence on innate immunity within neurodegenerative disease. Neurotherapeutics. 2024;21(6):e00476.","journal-title":"Neurotherapeutics"},{"issue":"8","key":"804_CR205","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","volume":"14","author":"GR Gibson","year":"2017","unstructured":"Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491\u2013502.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"804_CR206","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1152\/physrev.00018.2018","volume":"99","author":"JF Cryan","year":"2019","unstructured":"Cryan JF, O\u2019Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877\u20132013.","journal-title":"Physiol Rev"},{"issue":"9","key":"804_CR207","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1001\/jamaneurol.2024.2293","volume":"81","author":"TR Sampson","year":"2024","unstructured":"Sampson TR. Fecal microbiome transplants for Parkinson disease. JAMA Neurol. 2024;81(9):911\u20133.","journal-title":"JAMA Neurol"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00804-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00804-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00804-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T08:32:34Z","timestamp":1738225954000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00804-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":207,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00804-5","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give their consent to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"T.R.S. is a listed inventor on institutionally-assigned IP surrounding the microbiome and PD. M.G.T. has served as a member of The Michael J. Fox Foundation Scientific Advisory Board and serves on the Parkinson\u2019s Foundation Scientific Advisory Board, the Weston Family Foundation Advisory Board, the Alzheimer\u2019s Association Medical and Scientific Advisory Group, and as advisor for NysnoBio, IMMvention, Ventus, iMetabolic Pharma, Longevity Inc, Merck, NovoNordisk, Forward Therapeutics, Jaya, Longeveron, and Alnylam. She has received grants from MJFF\/ASAP, Parkinson\u2019s Foundation, and the National Institutes of Health (NIH). She is Editor-in-Chief for Nature Partner Journal\n                      Parkinson\u2019s Disease\n                      , and serves as Associate Editor for\n                      Science Advances\n                      ,\n                      Alzheimer\u2019s & Dementia: Translational Research and Clinical Interventions\n                      , and the\n                      Journal of Neuroinflammation\n                      . A.B.W. has served as a member of The Michael J. Fox Executive Foundation (MJFF) Scientific Advisory Board and is a paid consultant for SciNeuro, Inc, and has been a paid consultant for EscapeBio Inc.; and has received research grants from Biogen Inc. and EscapeBio, Inc., as well as MJFF, ASAP Foundation, Parkinson\u2019s Foundation, and the National Institutes of Health (NIH). A.B.W. is part owner of a series of LRRK2 kinase inhibitors (WO 2013166276) and part owner of induced-pluripotent stem cell lines of early-onset PD distributed by Cedars Sinai. R.A.L. receives authorship royalties from UpToDate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}